Your browser doesn't support javascript.
loading
Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates.
Miller, P D; Pannacciulli, N; Malouf-Sierra, J; Singer, A; Czerwinski, E; Bone, H G; Wang, C; Huang, S; Chines, A; Lems, W; Brown, J P.
Affiliation
  • Miller PD; Colorado Center for Bone Research, 13991 Jubilee Trail, Pine, CO, 80470, USA. millerccbr@gmail.com.
  • Pannacciulli N; Amgen Inc., Thousand Oaks, CA, USA.
  • Malouf-Sierra J; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Singer A; Georgetown University Medical Center, Washington, DC, USA.
  • Czerwinski E; Krakow Medical Center, Krakow, Poland.
  • Bone HG; Michigan Bone and Mineral Clinic, Detroit, MI, USA.
  • Wang C; Amgen Inc., Thousand Oaks, CA, USA.
  • Huang S; Amgen Inc., Thousand Oaks, CA, USA.
  • Chines A; Amgen Inc., Thousand Oaks, CA, USA.
  • Lems W; VU University Medical Center, Amsterdam, The Netherlands.
  • Brown JP; CHU de Québec Research Centre and Laval University, QC, Québec, Canada.
Osteoporos Int ; 31(1): 181-191, 2020 Jan.
Article in En | MEDLINE | ID: mdl-31776637
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Diphosphonates / Bone Density Conservation Agents / Denosumab Type of study: Clinical_trials Limits: Aged / Female / Humans / Middle aged Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Diphosphonates / Bone Density Conservation Agents / Denosumab Type of study: Clinical_trials Limits: Aged / Female / Humans / Middle aged Language: En Year: 2020 Type: Article